Skip to content
Kardigan logo — Cardiovascular disease is the leading cause of death in the...

Kardigan

Cardiovascular disease is the leading cause of death in the world. We are developing novel medicines to change that.

Founded 2023 United States Princeton, United States 198 employees

General Information

Company Name Kardigan
Founded Year 2023
Location United States Princeton, United States
Employees 198
Business Model B2B, B2B2C, Platform
Revenue Model Product Sales, Licensing, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Kardigan. To contact Kardigan, visit kardigan.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Kardigan compare?

A PDF of Kardigan and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Kardigan soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Kardigan

Kardigan, founded in 2023, is making strides in the biotech space by targeting the global challenge of cardiovascular disease, the leading cause of death worldwide. Their mission, aptly captured in their slogan, "Cardiovascular disease is the leading cause of death in the world. We are developing novel medicines to change that," emphasizes their innovative approach.

Specializing in cardiovascular drug development, Kardigan aims to move beyond mere symptom management towards functional cures. The company adopts a personalized medicine approach by aligning disease drivers with treatment responders identified through clinical trials. This patient-driven strategy aims not just to alleviate symptoms but to modify the disease’s underlying pathophysiology.

Operating on both the East and West Coast, Kardigan boasts a team rich in cardiovascular, biotechnology, and operational expertise. While specific details about investments are not provided, their strategic focus and innovative platform position them as a promising candidate for future investor interest.

Business keywords: Cardiovascular Medicine, Heart Health Innovation, Drug Development, Functional Cures, Disease Pathophysiology, Precision Medicine, Clinical Trials, Patient-Driven Healthcare, Pharmaceutical Research, East Coast Operations, West Coast Operations, Healthcare Modernization, Treatment Response Matching

Services & Products

Development of treatments for cardiovascular diseases
Personalized cardiovascular medicine
Clinical pipeline for specific cardiac conditions
Cardiac research and education

Target Customers

Patients with cardiovascular diseases Medical professionals specializing in cardiology Pharmaceutical and biotech partners Healthcare providers and hospitals Patient advocacy groups

No funding data available for Kardigan yet.

Kardigan Alternatives & Competitors

Kardigan vs

Engaging Innate Immunity to Cure Cancer

Series B
9 employees
Biotechnology, Health Care
Kardigan vs
Avenzo Therapeutics
Avenzo Therapeutics United States

Developing the next generation of oncology therapies for patients

61 employees
Biotechnology, Health Care
Kardigan vs
Sano Genetics
Sano Genetics United Kingdom

Accelerating the world's transition to precision medicine.

50 employees
Biopharma, Biotechnology

FAQ About Kardigan

Cardiovascular disease is the leading cause of death in the world. We are developing novel medicines to change that.
Kardigan was founded in 2023.
Kardigan is headquartered in Princeton, United States.
Kardigan has a B2B, B2B2C and Platform business model. Its revenue comes from Product Sales, Licensing and Performance Based.
Kardigan has approximately 198 employees.
Kardigan offers: Development of treatments for cardiovascular diseases, Personalized cardiovascular medicine, Clinical pipeline for specific cardiac conditions, Cardiac research and education.
Top alternatives and competitors to Kardigan include Primmune Therapeutics, Avenzo Therapeutics, Sano Genetics, Pathos, Clint. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kardigan and Primmune Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kardigan, https://bouncewatch.com/company/kardigan, updated 1 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout